Advertisement

Topics

HIFU Prostate Services, LLC Company Profile

11:59 EDT 21st March 2019 | BioPortfolio

At HIFU Prostate Services (HPS), our mission is to partner with physicians to deliver the highest quality of care, support and technology to the patient and to the urology community for the treatment of localized prostate cancer using high intensity focused ultrasound (HIFU). HPS was founded in 2015 by a seasoned management team with over 50 years of experience in the healthcare industry and over 30 years focused on HIFU technologies. The company is headquartered in Charlotte, N.C.


News Articles [972 Associated News Articles listed on BioPortfolio]

Comparing HIFU and Radioiodine for Toxic Thyroid Nodules

This study compares the results between HIFU and radioiodine treatments for toxic thyroid nodules. How do they measure up? Clinical Endocrinology

GU/Prostate Cancer | Medscape

Review in-depth clinical information, latest medical news, and guidelines on prostate cancer and prostate cancer treatment including prostate cancer surgery. Learn about prostate cancer prognosis for ...

EDAP TMS SA: EDAP Announces Sales of Two Additional Focal One Devices in Brazil

EDAP TMS SA (Nasdaq: EDAP) the global leader in therapeutic ultrasound, announced today that the Company has completed sales of two additional Focal One High Intensity Focused Ultrasound (HIFU) device...

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

What you need to knowPSA testing has increased the number of men diagnosed with and treated for prostate cancer, but many of these men would never have experienced any symptoms or death from prostate....

Laser-targeted removal of prostate tumours is as effective as complete prostate removal

A research group led by prostate cancer treatment pioneer Dr Eric Walser, have shown that selectively destroying cancerous prostate tissue is as effective as complete prostate removal or radiation th...

Enlarged prostate could actually be stopping tumour growth, simulations show

For men older than about 60, an enlarged prostate means feeling the urge to make a pit stop way too often throughout the day. But a new study shows that if these men also happen to have prostate canc...

Surgery & combination therapy optimises results in aggressive prostate cancer management

Men presenting with aggressive prostate cancer - Gleason Score of 9 or 10 - comprise most of those who will die from prostate cancer worldwide, and despite surgical removal of the prostate (radical pr...

Biological markers that could guide treatment for prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, researchers have discovered. The research found for...

PubMed Articles [1890 Associated PubMed Articles listed on BioPortfolio]

Medium term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using HIFU for primary localized prostate cancer.

To report medium-term oncological outcomes in patients receiving primary focal treatment with HIFU for PCa.

Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Technical Background and Overview of Current Clinical Applications (Part 1).

 Extracorporeal high-intensity focused ultrasound (HIFU) is a promising method for the noninvasive thermal ablation of benign and malignant tissue. Current HIFU treatments are performed under ultras...

Misinformation on the Internet regarding Ablative Therapies for Prostate Cancer.

To evaluate the quality of web-based information on ablative therapies for prostate cancer METHODS: The two most common search engines (Google and Bing) were queried for the following terms: "prostate...

Twitter Response to the 2018 United States Preventive Services Task Force Guidelines on Prostate Cancer Screening.

Prostate cancer screening reduces advanced disease and prostate cancer death but is controversial due to downstream harms including unnecessary biopsies and overtreatment. In 2012 the United States Pr...

HIFU treatment for fibroadenoma - a clinical study at National Scientific Research Centre, Astana, Kazakhstan.

This randomized controlled study evaluated effect of low frequency high intensity focused ultrasound (HIFU) in 80 women with breast fibroadenomas randomly and evenly divided into main and control grou...

Clinical Trials [3804 Associated Clinical Trials listed on BioPortfolio]

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

The Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatm...

MRI Guided Transurethral HIFU for Various Prostate Diseases

This study assesses feasibility and safety, the primary outcomes, of MRI guided transurethral high intensity focused ultrasound (HIFU) ablation for prostate diseases (PD). We will enrol 10...

HIFU Hemi-ablation Combined With Short-term Androgen Deprivation Therapy for Localized Prostate Cancer.

The current study aims to examine the hypothesis that combining the focal effects of HIFU with the systemic effects of androgen deprivation therapy might eradicate the prostatic cancer cel...

High Resolution PET-MRI Before Prostate Cancer HIFU

This prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-fluciclovine PET-MRI) will detect prostate cancers n...

Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada

An investigational study on the use of HIFU in the management of localized prostate cancer as a primary non-comparative study High intensity focused ultrasound (HIFU) is a non-invasive ac...

Companies [700 Associated Companies listed on BioPortfolio]

HIFU Prostate Services, LLC

At HIFU Prostate Services (HPS), our mission is to partner with physicians to deliver the highest quality of care, support and technology to the patient and to the urology communi...

US HIFU, LLC

US HIFU, LLC, a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medical devic...

USHIFU, LLC

USHIFU, LLC (US HIFU), a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medi...

EDAP TMS

EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically proven choice for High Intensity Focused Ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is show...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

More Information about "HIFU Prostate Services, LLC" on BioPortfolio

We have published hundreds of HIFU Prostate Services, LLC news stories on BioPortfolio along with dozens of HIFU Prostate Services, LLC Clinical Trials and PubMed Articles about HIFU Prostate Services, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HIFU Prostate Services, LLC Companies in our database. You can also find out about relevant HIFU Prostate Services, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record